One hundred patients of essential hypertension uncomplicated at the initial registration with an average of about 11 years followup attending the Hypertension Clinic, PMRC Research Centre, Sir Ganga Ram Hospital, Lahore were reviewed for various metabolic and cardiovascular complication. Hyperlipidaemia was observed in 44 (4% per annum) of which 50% developed cardiovascular complications compared to 41.07% of 56 non-hyperlipidaemic hypertensives. Incidence of coronary heart disease (CHD) was 38.64% and hypertensive heart disease (HHD) 20.45% compared to 23..21% of CHD and 12.50% HHD among non-hyperlipidaemics. oUt of the hyperlipidaemics 6 were found to have obesity and diabetes mellitus with a familial predisposition in 4 (66.67%). Different behavioura characteristics including age, sex, family predisposition, smoking habits, height and weight were comparable between the two groups. Severity of hypertension and control status of blood pressure did not differ significantly except that the hyperlipidaemic group were prescribed with diuretics and Beta-blockers more frequently and for longer durations. It is concluded from the results that with similar behavioural pattern and a comparable control status of hypertension, higher incidence of hyperlipidaemia is probably related to pharmacological therapy resulting in higher cardiovascular complications. It is, therefore, recommended to use these drugs with regular monitoring of lipid levels and cardiovascular status, particularly with familial tendencies.